Endocrinology and Metabolic syndrome

Welcome

About the Conference

The 3rd World Congress on Endocrinology and Metabolic Syndrome is an international scientific platform dedicated to advancing knowledge in endocrinology, metabolism, diabetes, obesity, hormonal disorders, and metabolic syndrome. The congress brings together experts from clinical practice, academia, research, healthcare, and industry to discuss current challenges, emerging discoveries, and advances in endocrine and metabolic medicine.

The scientific program covers areas such as diabetes and metabolism, obesity, thyroid and adrenal disorders, pituitary diseases, reproductive endocrinology, pediatric endocrinology, metabolic responses and nutrition, endocrine oncology, cardiovascular endocrinology, and clinical research. It provides an opportunity to exchange research findings, discuss innovative treatments, and explore multidisciplinary approaches to improving endocrine health. 

Why Attend the Conference

Attending the 3rd World Congress on Endocrinology and Metabolic Syndrome provides an opportunity to learn about the latest advances in endocrine and metabolic research, clinical management, diagnostics, and therapeutic approaches. Participants can gain insights from leading experts and explore emerging developments in diabetes, obesity, metabolic syndrome, hormonal disorders, and endocrine diseases.

The congress also offers opportunities to present research, exchange scientific knowledge, build international collaborations, expand professional networks, and explore emerging technologies and treatment strategies. It is particularly valuable for researchers, clinicians, academicians, healthcare professionals, students, and industry representatives seeking to remain updated with developments in endocrine and metabolic medicine.

Target Audience

The 3rd World Congress on Endocrinology and Metabolic Syndrome is designed for professionals and researchers involved in endocrinology, diabetes, metabolic health, obesity, hormonal disorders, and related clinical and scientific fields. The congress brings together experts from academia, healthcare, research institutions, and industry to exchange knowledge and discuss emerging developments.

• Endocrinologists
• Diabetologists
• Metabolic Disease Specialists
• Obesity Specialists
• Physicians
• Clinicians
• Cardiologists
• Pediatric Endocrinologists
• Reproductive Endocrinologists
• Clinical Researchers
• Medical Researchers
• Scientists
• Academicians
• Professors
• Nutritionists
• Dietitians
• Diabetes Educators
• Pharmacologists
• Clinical Pharmacists
• Healthcare Professionals
• Nursing Professionals
• Public Health Professionals
• Geneticists
• Molecular Biologists
• Biochemists

Sections & Tracks

Track 1: Endocrinology:

Endocrinology focuses on the study of hormones, endocrine glands, and their role in regulating essential physiological processes. This track explores endocrine disorders, hormonal imbalances, advanced diagnostic approaches, emerging therapies, and recent developments in clinical endocrinology. It provides a platform for discussing innovative strategies for improving endocrine health and patient outcomes.

Track 2: Metabolic Syndrome:

Metabolic Syndrome explores the interconnected conditions of abdominal obesity, insulin resistance, hypertension, dyslipidemia, and impaired glucose regulation. This session focuses on early detection, prevention, risk assessment, lifestyle interventions, and therapeutic strategies. Researchers can present new approaches for reducing cardiometabolic risks and improving long-term health outcomes.

Track 3: Diabetes

Diabetes focuses on the prevention, diagnosis, management, and treatment of diabetes mellitus. Topics include Type 1 and Type 2 diabetes, glycemic control, insulin therapy, diabetes complications, emerging medications, and innovative monitoring technologies. The session highlights advances aimed at improving disease management and quality of life.

Track 4: Obesity

Obesity explores the complex biological, genetic, behavioral, and environmental factors contributing to excessive weight gain. This track covers obesity prevention, nutrition, lifestyle modification, pharmacological treatments, bariatric approaches, and emerging weight-management strategies. Special attention is given to the relationship between obesity and metabolic disorders.

Track 5: Thyroid

Thyroid focuses on disorders affecting thyroid function, including hypothyroidism, hyperthyroidism, thyroiditis, autoimmune thyroid diseases, and thyroid nodules. The session covers modern diagnostic techniques, biomarkers, treatment strategies, and advances in thyroid disease management. Researchers can discuss emerging approaches for improving thyroid health and clinical outcomes.

Track 6: Adrenal

Adrenal explores disorders involving adrenal hormones and gland function, including adrenal insufficiency, Cushing’s syndrome, hyperaldosteronism, and adrenal tumors. This track covers hormonal regulation, diagnostic challenges, clinical management, and emerging therapeutic approaches. It provides opportunities to discuss advances in adrenal disease research and patient care.

Track 7: Pituitary

Pituitary focuses on pituitary hormones, gland disorders, pituitary tumors, and hormonal regulation. Topics include growth hormone disorders, prolactin abnormalities, pituitary adenomas, hypopituitarism, and diagnostic technologies. The session highlights innovative clinical and research approaches for improving diagnosis and treatment.

Track 8: Reproductive Endocrinology

Reproductive Endocrinology explores hormonal mechanisms involved in fertility, reproductive health, and endocrine-related reproductive disorders. This track covers infertility, polycystic ovary syndrome, menopause, hormonal disorders, fertility treatments, and reproductive hormone regulation. Researchers can share advances in reproductive medicine and endocrine therapies.

Track 9: Pediatric Endocrinology

Pediatric Endocrinology focuses on endocrine and metabolic disorders affecting children and adolescents. Topics include childhood diabetes, growth abnormalities, puberty disorders, pediatric obesity, thyroid disorders, and congenital endocrine conditions. The session highlights early diagnosis, preventive care, and innovative treatment approaches for young patients.

Track 10: Neuroendocrinology

Neuroendocrinology explores the interaction between the nervous system and endocrine system in regulating physiological and behavioral processes. This track covers stress hormones, hypothalamic function, neuroendocrine signaling, and related disorders. Discussions will focus on emerging discoveries connecting hormonal regulation with neurological and metabolic health.

Track 11: Nutrition

Nutrition focuses on the relationship between dietary patterns, nutrient metabolism, and endocrine and metabolic health. Topics include therapeutic nutrition, micronutrients, dietary interventions, metabolic regulation, and nutritional strategies for diabetes and obesity. The session emphasizes evidence-based approaches for disease prevention and healthy lifestyle management.

Track 12: Endocrine Oncology

Endocrine Oncology focuses on cancers and tumors involving endocrine tissues and hormone-related pathways. This track covers thyroid cancer, adrenal tumors, neuroendocrine tumors, molecular diagnostics, targeted therapies, and personalized treatment approaches. Researchers can present advances in cancer biology, diagnosis, and innovative therapeutic strategies.

Tracks13. Bone Metabolism

Bone Metabolism explores the biological mechanisms regulating bone formation, mineral balance, and skeletal health. Topics include osteoporosis, calcium and vitamin D metabolism, parathyroid disorders, bone mineral density, and metabolic bone diseases. The session highlights new diagnostic and therapeutic strategies for maintaining bone health and preventing fractures.

Track 14: Precision Medicine

Precision Medicine focuses on individualized approaches to diagnosing and treating endocrine and metabolic disorders. This track covers genomics, biomarkers, molecular diagnostics, pharmacogenomics, and personalized therapeutic strategies. Researchers can explore how patient-specific information can improve treatment selection, effectiveness, and clinical outcomes.

Track 15: Digital Endocrinology

Digital Endocrinology explores the integration of digital technologies into endocrine and metabolic healthcare. Topics include artificial intelligence, wearable devices, continuous glucose monitoring, telemedicine, mobile health applications, remote patient monitoring, and digital therapeutics. The session highlights how technology can support early diagnosis, continuous monitoring, personalized care, and improved patient engagement.

Market Analysis

The global market surrounding endocrine and metabolic health is expanding as obesity, diabetes, metabolic syndrome, and other chronic endocrine disorders continue to create substantial healthcare demand. A 2026 market analysis estimates the global metabolic syndrome market at approximately US$97.05 billion in 2026, up from US$90.34 billion in 2025, representing a 7.4% CAGR. Growth is associated with increasing obesity, insulin resistance, metabolic disease diagnosis, preventive healthcare initiatives, and cardiovascular complications.

The market is also being influenced by advances in diabetes therapeutics, obesity management, weight-loss interventions, continuous glucose monitoring, digital health, personalized medicine, metabolic diagnostics, and innovative endocrine therapies. These developments create opportunities for pharmaceutical companies, biotechnology organizations, medical-device manufacturers, healthcare providers, research institutions, and digital-health companies. The growing intersection between endocrinology, metabolic health, technology, and preventive medicine makes this field an important area for scientific and commercial collaboration.